if the assumption above is in the right ballpark .... given they have around $5M of fixed costs (ATM before adding new US costs) this would mean about $33M in total sales to real customers for Archemy units (ie. not discounted academic machines) is required to have ongoing income to cover fixed costs. Maybe not that big a stretch to sell this value of Archemy units ? With contract work on top being bonus.
This is clearly a really rough view and with a BIG assumption on the value of licensing, maintenance and support income !! Just for interest.
$12.2M revenue for the last 12 months, page-27
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AL3 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $62.22M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 15.5¢ | $522.8K | 3.188M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 88719 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 284052 | 5 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| AL3 (ASX) Chart |